Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru


ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Лечебное дело
2021 / N 2

Трансдермальные системы доставки местных средств: новые перспективы
С.Г. Гаврилов

Список литературы

1. Martinez-Zapata MJ, Vernooij RWM, Simancas-Racines D, Uriona Tuma SM, Stein AT, Moreno Carriles RMM, Vzargas E, Bonfill Cosp X. Phlebotonics for venous insufficiency. Cochrane Database of Systematic Reviews 2020 Nov;11(11):CD003229.
2. Российские клинические рекомендации по диагностике и лечению хронических заболеваний вен. Флебология 2018;12(3):146-240.
3. Lurie F, Passman M, Meisner M, Dalsing M, Masuda E, Welch H, Bush RL, Blebea J, Carpentier PH, De Maeseneer M, Gasparis A, Labropoulos N, Marston WA, Rafetto J, Santiago F, Shortell C, Uhl JF, Urbanek T, van Rij A, Eklof B, Gloviczki P, Kistner R, Lawrence P, Moneta G, Padberg F, Perrin M, Wakefield T. The 2020 update of the CEAP classification system and reporting standards. Journal of Vascular Surgery. Venous and Lymphatic Disorders 2020 May;8(3):342-52.
4. Селиверстов Е.И., Авакъянц И.П., Никишков А.С., Золотухин И.А. Эпидемиология хронических заболеваний вен. Флебология 2016;10(1):35-43.
5. Золотухин И.А., Селиверстов Е.И., Шевцов Ю.Н., Авакъянц И.П., Никишков А.И., Татаринцев А.М., Кириенко А.И. Распространенность хронических заболеваний вен: результаты популяционного эпидемиологического исследования. Флебология 2016;10(3):119-25.
6. Nicolaides A, Allegra C, Bergan J, Bradbury A, Cairols M, Carpentier P, Comerota AJ, Delis C, Eklof B, Fassiadis, Georgiou N, Geroulakos G, Hoffmann U, Jantet G, Jawien A, Kakkos SK, Kalodiki E, Labropoulos N, Neglen P, Pappas P, Partsch H, Perrin M, Rabe E, Ramelet AA, Vayssaira M, Ioannidou E, Taft A. Management of chronic venous disorders of the lower limbs: guidelines according to scientific evidence. International Angiology 2008 Mar;27(1):1-59.
7. Nicolaides A, Kakkos S, Baekgaard N, Comerota A, de Maesenner M, Eklof B, Giannoukas D, Lugli M, Maleti O, Myers K, Nelzén O, Partsch H, Perrin M. Management of chronic venous disorders of the lower limbs. Guidelines according to scientific evidence. Part I. International Angiology 2018 Jun;37(3):181-254.
8. Nicolaides A, Kakkos S, Baekgaard N, Comerota A, de Maeseneer M, Eklof B, Giannoukas A, Lugli M, Maleti O, Mansilha A, Myers KA, Nelzén O, Partsch H, Perrin M. Management of chronic venous disorders of the lower limbs. Guidelines according to scientific evidence. Part II. International Angiology 2020 Jun;39(3):175-240.
9. Tsouredos Y. Venous tone: are the phlebotonic properties predictive of a therapeutic benefit? A comprehensive view of our experience with Daflon 500 mg. Zeitschrift für Kardiologie 1991;80(Suppl 7):95-101.
10. Behar A, Lagrue G, Cohen-Boulakia F, Baillet J. Capillary filtration in idiopathic cyclic edema – effects of Daflon 500 mg. Nuklearmedizin 1988 Jun;27(3):105-7.
11. Holland LC, Norris JM. Medical grade honey in the management of chronic venous leg ulcers. International Journal of Surgery (London, England) 2015 Aug;20:17-20.
12. Флебология. Руководство для врачей. Под ред. Савельева В.С. М.: Медицина; 2001. 661 с.
13. Mittal S, Chaudhary A, Chaudhary A, Kumar A. Proniosomes: the effective and efficient drug-carrier system. Therapeutic Delivery 2020 Feb;11(2):125-37.
14. Opatha SAT, Titapiwatanakun V, Chutoprapat R. Transfersomes: a promising nanoencapsulation technique for transdermal drug delivery. Pharmaceutics 2020;12(9):855.
15. Савельева М.И., Сычев Д.А. Возможности трансдермальных систем доставки лекарственных средств, применяемых при хронических заболеваниях вен. Флебология 2018;12(1):40-9.
16. Madhav NVS, Saini A. Niosomes: a novel drug delivery system. International Journal of Research in Pharmacy and Chemistry 2011;1(3):498-511.
17. Marianecci C, Di Marzio L, Rinaldi F, Celia C, Paolino D, Alhaique F, Esposito S, Carafa M. Niosomes from 80s to present: the state of the art. Advances in Colloid and Interface Science 2014 Mar;205:187-206.
18. Kim EM, Jeong HJ. Liposomes: biomedical applications. Chonnam Medical Journal 2021 Jan;57(1):27-35.
19. Yuba E. Development of functional liposomes by modification of stimuli-responsive materials and their biomedical applications. Journal of Materials Chemistry B 2020 Feb;8(6):1093-107.
20. Sercombe L, Veerati T, Moheimani F, Wu SY, Sood AK, Hua S. Advances and challenges of liposome assisted drug delivery. Frontiers in Pharmacology 2015 Dec;6:286.
21. Percutaneous penetration enhancers chemical methods in penetration enhancement: nanocarriers. Dragičević N, Maibach HI, editors. Berlin, Heidelberg: Springer; 2016. 384 p.
22. Betz G, Nowbakht P, Imboden R, Imanidis G. Heparin penetration into and permeation through human skin from aqueous and liposomal formulations in vitro. International Journal of Pharmaceutics 2001 Oct;228(1-2):147-59.
23. Chen S, Hanning S, Falconer J, Locke M, Wen J. Recent advances in non-ionic surfactant vesicles (niosomes): fabrication, characterization, pharmaceutical and cosmetic applications. European Journal of Pharmaceutics and Biopharmaceutics 2019 Nov;144:18-39.
24. Rajera R, Nagpal K, Singh SK, Mishra DN. Niosomes: a controlled and novel drug delivery system. Biological & Pharmaceutical Bulletin 2011;34(7):945-53.
25. Sharma D, Ali AAE, Aate JR. Niosomes as novel drug delivery system: review article. PharmaTutor 2018 Mar;6(3):58-65.
26. Alkilani AZ, McCrudden MTC, Donnelly RF. Transdermal drug delivery: innovative pharmaceutical developments based on disruption of the barrier properties of the stratum corneum. Pharmaceutics 2015 Oct;7(4):438-70.
27. Fang JY, Hong CT, Chiu WT, Wang YY. Effect of liposomes and niosomes on skin permeation of enoxacin. International Journal of Pharmaceutics 2001 May;219(1-2):61-72.
28. Manconi M, Sinico C, Valenti D, Lai F, Fadda AM. Niosomes as carriers for tretinoin. III. A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin. International Journal of Pharmaceutics 2006;27;311(1-2):11-9.
29. Patel KK, Kumar H, Thakkar HP. Formulation of niosomal gel for enhanced transdermal lopinavir delivery and its comparative evaluation with ethosomal gel. AAPS PharmSciTech 2012 Dec;13(4):1502-10.
30. Manosroi A, Chankhampan C, Ofoghi H, Manosroi W, Manosroi J. Low cytotoxic elastic niosomes loaded with salmon calcitonin on human skin fibroblasts. Human & Experimental Toxicology 2013;32(1):31-44.
31. El-Menshawe SF, Hussein AK. Formulation and evaluation of meloxicam niosomes as vesicular carriers for enhanced skin delivery. Pharmaceutical Development and Technology 2013 Jul-Aug;18(4):779-86.
32. Tavano L, Gentile L, Oliviero Rossi C, Muzzalupo R. Novel gel-niosomes formulations as multicomponent systems for transdermal drug delivery. Colloids and Surfaces B: Biointerfaces 2013;110:281-8.
33. Венарус гель. Декларация о соответствии ЕАЭС N RU Д-RU.НВ32.В.15801/20. Дата регистрации 03 ноября 2020.
34. Голованова О.В., Ефремова О.И., Золотухин И.А., Кузнецов А.Н. Результаты клинического применения комбинированного местного средства у пациентов с хроническими заболеваниями вен нижних конечностей. Лечебное дело 2021;1:83-8.

References

1. Martinez-Zapata MJ, Vernooij RWM, Simancas-Racines D, Uriona Tuma SM, Stein AT, Moreno Carriles RMM, Vargas E, Bonfill Cosp X. Phlebotonics for venous insufficiency. Cochrane Database of Systematic Reviews 2020 Nov;11(11):CD003229.
2. Diagnostics and treatment of chronic venous disease. Guidelines of the Russian Phlebological Association. Phlebologiya. Journal of Venous Disorders 2018;12(3):146-240 (In Russian).
3. Lurie F, Passman M, Meisner M, Dalsing M, Masuda E, Welch H, Bush RL, Blebea J, Carpentier PH, De Maeseneer M, Gasparis A, Labropoulos N, Marston WA, Rafetto J, Santiago F, Shortell C, Uhl JF, Urbanek T, van Rij A, Eklof B, Gloviczki P, Kistner R, Lawrence P, Moneta G, Padberg F, Perrin M, Wakefield T. The 2020 update of the CEAP classification system and reporting standards. Journal of Vascular Surgery. Venous and Lymphatic Disorders 2020 May;8(3):342-52.
4. Seliverstov EI, Avakyants IP, Nikishkov AS, Zolotukhin IA. Epidemiology of chronic venous diseases. Phlebologiya. Journal of Venous Disorders 2016;10(1):35-43 (In Russian).
5. Zolotukhin IA, Seliverstov EI, Shevtsov YuN, Avakyants IP, Nikishkov AI, Tatarintsev AM, Kiriyenko AI. Prevalence of chronic venous diseases: results of population epidemiological study. Phlebologiya. Journal of Venous Disorders 2016;10(3):119-25 (In Russian).
6. Nicolaides A, Allegra C, Bergan J, Bradbury A, Cairols M, Carpentier P, Comerota AJ, Delis C, Eklof B, Fassiadis, Georgiou N, Geroulakos G, Hoffmann U, Jantet G, Jawien A, Kakkos SK, Kalodiki E, Labropoulos N, Neglen P, Pappas P, Partsch H, Perrin M, Rabe E, Ramelet AA, Vayssaira M, Ioannidou E, Taft A. Management of chronic venous disorders of the lower limbs: guidelines according to scientific evidence. International Angiology 2008 Mar;27(1):1-59.
7. Nicolaides A, Kakkos S, Baekgaard N, Comerota A, de Maesenner M, Eklof B, Giannoukas D, Lugli M, Maleti O, Myers K, Nelzén O, Partsch H, Perrin M. Management of chronic venous disorders of the lower limbs. Guidelines according to scientific evidence. Part I. International Angiology 2018 Jun;37(3):181-254.
8. Nicolaides A, Kakkos S, Baekgaard N, Comerota A, de Maeseneer M, Eklof B, Giannoukas A, Lugli M, Maleti O, Mansilha A, Myers KA, Nelzén O, Partsch H, Perrin M. Management of chronic venous disorders of the lower limbs. Guidelines according to scientific evidence. Part II. International Angiology 2020 Jun;39(3):175-240.
9. Tsouredos Y. Venous tone: are the phlebotonic properties predictive of a therapeutic benefit? A comprehensive view of our experience with Daflon 500 mg. Zeitschrift für Kardiologie 1991;80(Suppl 7):95-101.
10. Behar A, Lagrue G, Cohen-Boulakia F, Baillet J. Capillary filtration in idiopathic cyclic edema – effects of Daflon 500 mg. Nuklearmedizin 1988 Jun;27(3):105-7.
11. Holland LC, Norris JM. Medical grade honey in the management of chronic venous leg ulcers. International Journal of Surgery (London, England) 2015 Aug;20:17-20.
12. Phlebology. Guidelines for physicians. Savelyev VS, editor. Moscow: Meditsina; 2001. 661 p. (In Russian).
13. Mittal S, Chaudhary A, Chaudhary A, Kumar A. Proniosomes: the effective and efficient drug-carrier system. Therapeutic Delivery 2020 Feb;11(2):125-37.
14. Opatha SAT, Titapiwatanakun V, Chutoprapat R. Transfersomes: a promising nanoencapsulation technique for transdermal drug delivery. Pharmaceutics 2020;12(9):855.
15. Savelyeva MI, Sychev DA. Potential of transdermal drug delivery systems used in chronic venous diseases treatment. Phlebologiya. Journal of Venous Disorders 2018;12(1):40-9 (In Russian).
16. Madhav NVS, Saini A. Niosomes: a novel drug delivery system. International Journal of Research in Pharmacy and Chemistry 2011;1(3):498-511.
17. Marianecci C, Di Marzio L, Rinaldi F, Celia C, Paolino D, Alhaique F, Esposito S, Carafa M. Niosomes from 80s to present: the state of the art. Advances in Colloid and Interface Science 2014 Mar;205:187-206.
18. Kim EM, Jeong HJ. Liposomes: biomedical applications. Chonnam Medical Journal 2021 Jan;57(1):27-35.
19. Yuba E. Development of functional liposomes by modification of stimuli-responsive materials and their biomedical applications. Journal of Materials Chemistry B 2020 Feb;8(6):1093-107.
20. Sercombe L, Veerati T, Moheimani F, Wu SY, Sood AK, Hua S. Advances and challenges of liposome assisted drug delivery. Frontiers in Pharmacology 2015 Dec;6:286.
21. Percutaneous penetration enhancers chemical methods in penetration enhancement: nanocarriers. Dragičević N, Maibach HI, editors. Berlin, Heidelberg: Springer; 2016. 384 p.
22. Betz G, Nowbakht P, Imboden R, Imanidis G. Heparin penetration into and permeation through human skin from aqueous and liposomal formulations in vitro. International Journal of Pharmaceutics 2001 Oct;228(1-2):147-59.
23. Chen S, Hanning S, Falconer J, Locke M, Wen J. Recent advances in non-ionic surfactant vesicles (niosomes): fabrication, characterization, pharmaceutical and cosmetic applications. European Journal of Pharmaceutics and Biopharmaceutics 2019 Nov;144:18-39.
24. Rajera R, Nagpal K, Singh SK, Mishra DN. Niosomes: a controlled and novel drug delivery system. Biological & Pharmaceutical Bulletin 2011;34(7):945-53.
25. Sharma D, Ali AAE, Aate JR. Niosomes as novel drug delivery system: review article. PharmaTutor 2018 Mar;6(3):58-65.
26. Alkilani AZ, McCrudden MTC, Donnelly RF. Transdermal drug delivery: innovative pharmaceutical developments based on disruption of the barrier properties of the stratum corneum. Pharmaceutics 2015 Oct;7(4):438-70.
27. Fang JY, Hong CT, Chiu WT, Wang YY. Effect of liposomes and niosomes on skin permeation of enoxacin. International Journal of Pharmaceutics 2001 May;219(1-2):61-72.
28. Manconi M, Sinico C, Valenti D, Lai F, Fadda AM. Niosomes as carriers for tretinoin. III. A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin. International Journal of Pharmaceutics 2006;27;311(1-2):11-9.
29. Patel KK, Kumar H, Thakkar HP. Formulation of niosomal gel for enhanced transdermal lopinavir delivery and its comparative evaluation with ethosomal gel. AAPS PharmSciTech 2012 Dec;13(4):1502-10.
30. Manosroi A, Chankhampan C, Ofoghi H, Manosroi W, Manosroi J. Low cytotoxic elastic niosomes loaded with salmon calcitonin on human skin fibroblasts. Human & Experimental Toxicology 2013;32(1):31-44.
31. El-Menshawe SF, Hussein AK. Formulation and evaluation of meloxicam niosomes as vesicular carriers for enhanced skin delivery. Pharmaceutical Development and Technology 2013 Jul-Aug;18(4):779-86.
32. Tavano L, Gentile L, Oliviero Rossi C, Muzzalupo R. Novel gel-niosomes formulations as multicomponent systems for transdermal drug delivery. Colloids and Surfaces B: Biointerfaces 2013;110:281-8.
33. Venarus gel. Declaration of Conformity of the EAEU N RU D-RU. NV32. V. 15801/20. Registration date 2020 Nov 03. (In Russian).
34. Golovanova OV, Yefremova OI, Zolotukhin IA, Kuznetsov AN. Results of clinical use of a combined topical agent in patients with chronic venous diseases of the lower extremities. Lechebnoye Delo 2021;1:83-8 (In Russian).
  

[ Содержание выпуска N 2 | Выпуски журнала | Список журналов ]